Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Pathophysiology/Complications

Optimal Blood Glucose Control During 18 Years Preserves Peripheral Nerve Function in Patients With 30 Years’ Duration of Type 1 Diabetes

  1. Jakob R. Larsen, MD12,
  2. Hans Sjoholm, MD, PHD3,
  3. Kristian F. Hanssen, MD, PHD14,
  4. Leiv Sandvik, PHD5,
  5. Tore J. Berg, MD, PHD14 and
  6. Knut Dahl-Jorgensen12
  1. 1Diabetes Research Center, Aker and Ulleval University Hospitals, Oslo, Norway
  2. 2Pediatrics Department, Ulleval University Hospital, Oslo, Norway
  3. 3Neurophysiology Department, Ulleval University Hospital, Oslo, Norway
  4. 4Endocrinology Department, Aker University Hospital, Oslo, Norway
  5. 5Center for Clinical Research, Ulleval University Hospital, Oslo, Norway
  1. Address correspondence and reprint requests to Jakob R. Larsen, MD, Departement of Pediatrics, Aker and Ullevaal Diabetes Research Center, Ullevaal University Hospital, Oslo, Norway 0407. E-mail: j.r.larsen{at}ioks.uio.no
Diabetes Care 2003 Aug; 26(8): 2400-2404. https://doi.org/10.2337/diacare.26.8.2400
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Tables

  • Table 1—

    Demographic data in 1999 at 18-year follow-up in groups according to tertiles of mean HbA1c over 18 years

    HbA1c ≤7.8%HbA1c >7.8 and <8.4%HbA1c ≥8.4%
    n131115
    Sex distribution: men/women6/78/39/6
    Age (range)43 (35–53)42.5 (36–58)43 (38–53)
    Duration of diabetes (years)29.5 ± 3.528.4 ± 3.632 ± 5
    HbA1c over 18 years (%)7.3 ± 0.48.1 ± 0.19.1 ± 0.9
    HbA1c (%)8.0 ± 0.88.6 ± 1.09.4 ± 1.5
    Systolic blood pressure (mmHg)128 ± 12133 ± 21126 ± 11
    Diastolic blood pressure (mmHg)79 ± 1185 ± 977 ± 8
    BMI (kg/m2)22 ± 223 ± 223 ± 6
    Total cholesterol (mmol/l)5.4 ± 0.85.2 ± 0.55.4 ± 0.7
    LDL cholesterol (mmol/l)3.1 ± 0.93.1 ± 0.63.2 ± 0.8
    HDL cholesterol (mmol/l)2.0 ± 0.31.7 ± 0.31.6 ± 0.4
    Triglycerides (mmol/l)0.7 ± 0.21.0 ± 0.31.4 ± 1.6
    Total cholesterol/HDL cholesterol ratio2.8 ± 0.73.2 ± 0.73.5 ± 1.0
    Microalbuminuria013
    Overt nephropathy002
    Current smokers066
    Patients on antihypertensive treatment223
    Patients on lipid-lowering medication005
    • Data are means ± 1 SD.

  • Table 2—

    Nerve function in 1982, 1990, and 1999 for tertiles of HbA1c

    HbA1c tertilesHbA1c ≤ 7.8% (n = 13)HbA1c 7.9%–8.3% (n = 11)HbA1c ≥ 8.4% (n = 15)
    Sensory sural NCV in 198251 m/s (4)49 m/s (5)47 m/s (7)
    Sensory sural NCV in 199045 m/s (5)43 m/s (5)39 m/s (7)
    Sensory sural NCV in 199944 m/s (10)44 m/s (11)34 m/s (15)†
    Number of patients with undetectable sural NCV in 1999115
    Sensory sural NAPA in 19827.7 μV (5)8.3 μV (3)7.5 μV (3)
    Sensory sural NAPA in 19908.3 μV (4)6.7 μV (2)5.9 μV (4)
    Sensory sural NAPA in 19999.8 μV (9)4.8 μV (4)*3.4 μV (4)†
    Motor tibial NCV in 198248 m/s (5)46 m/s (5)47 m/s (7)
    Motor tibial NCV in 199042 m/s (3)43 m/s (4)38 m/s (5)
    Motor tibial NCV in 199943 m/s (6)*43 m/s (4)31 m/s (11)†
    Number of patients with undetectable tibial NCV in 1999004
    Tibial NAPA in 19994.9 mV (3)4.9 mV (2)2.6 mV
    Motor peroneal NCV in 198244 m/s (4)46 m/s (4)41 m/s (4)
    Motor peroneal NCV in 199042 m/s (2)44 m/s (4)38 m/s (5)
    Motor peroneal NCV in 199941 m/s (4)42 m/s (4)35 m/s (8)*
    Number of patients with undetectable peroneal NCV in 1999001
    NAPA peroneal nerve in 19992.7 mV (1)2.9 mV (1)1.7 mV (1)
    • Data are means ± 1 SD.

    • *

      ↵* P < 0.05;

    • †

      ↵† P < 0.01.

  • Table 3—

    Number of patients with none or one nerve with NCVs under the lower limit of the reference value and two or more nerves with NCVs under the lower limit of the reference value with patients grouped according to tertiles of mean HbA1c over 18 years

    NCV:
    Tertiles for HbA1cNone or one nerve below references for NCV(a)Minimum two nerves below references for NCV
    HbA1c < 7.8% (n = 13)12 (92%)1 (8%)
    HbA1c 7.9–8.4% (n = 11)10 (91%)1 (9%)
    HbA1c ≥ 8.4% (n = 15)8 (53%)7 (47%)
    NAPA:
    Tertiles for HbA1cNone or one nerve below references for NAPA(b)Minimum two nerves below references for NAPA
    HbA1c <7.8% (n = 13)10 (77%)3 (23%)
    HbA1c 7.9–8.4% (n = 11)8 (73%)3 (27%)
    HbA1c ≥8.4% (n = 15)8 (53%)7 (47%)
    • Data are n (%).

PreviousNext
Back to top
Diabetes Care: 26 (8)

In this Issue

August 2003, 26(8)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Optimal Blood Glucose Control During 18 Years Preserves Peripheral Nerve Function in Patients With 30 Years’ Duration of Type 1 Diabetes
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Optimal Blood Glucose Control During 18 Years Preserves Peripheral Nerve Function in Patients With 30 Years’ Duration of Type 1 Diabetes
Jakob R. Larsen, Hans Sjoholm, Kristian F. Hanssen, Leiv Sandvik, Tore J. Berg, Knut Dahl-Jorgensen
Diabetes Care Aug 2003, 26 (8) 2400-2404; DOI: 10.2337/diacare.26.8.2400

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Optimal Blood Glucose Control During 18 Years Preserves Peripheral Nerve Function in Patients With 30 Years’ Duration of Type 1 Diabetes
Jakob R. Larsen, Hans Sjoholm, Kristian F. Hanssen, Leiv Sandvik, Tore J. Berg, Knut Dahl-Jorgensen
Diabetes Care Aug 2003, 26 (8) 2400-2404; DOI: 10.2337/diacare.26.8.2400
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • CONCLUSIONS
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Insulin Resistance Is Associated With Enhanced Brain Glucose Uptake During Euglycemic Hyperinsulinemia: A Large-Scale PET Cohort
  • Processes Underlying Glycemic Deterioration in Type 2 Diabetes: An IMI DIRECT Study
  • COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic’s Impact in Type 1 and Type 2 Diabetes
Show more Pathophysiology/Complications

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.